Annual Long Term Debt
$66.90 K
-$83.70 K-55.58%
31 December 2023
Summary:
Processa Pharmaceuticals annual long term debt is currently $66.90 thousand, with the most recent change of -$83.70 thousand (-55.58%) on 31 December 2023. During the last 3 years, it has fallen by -$56.40 thousand (-45.74%). PCSA annual long term debt is now -96.96% below its all-time high of $2.20 million, reached on 31 December 2011.PCSA Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$2200.00
-$23.40 K-91.41%
30 September 2024
Summary:
Processa Pharmaceuticals quarterly long term debt is currently $2200.00, with the most recent change of -$23.40 thousand (-91.41%) on 30 September 2024. Over the past year, it has dropped by -$86.60 thousand (-97.52%). PCSA quarterly long term debt is now -99.89% below its all-time high of $1.97 million, reached on 30 September 2014.PCSA Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PCSA Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -55.6% | -97.5% |
| 3 y3 years | -45.7% | -75.0% |
| 5 y5 years | +100.0% | -98.7% |
PCSA Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -55.6% | +804.0% | -98.7% | at low |
| 5 y | 5 years | -55.6% | -98.9% | at low | |
| alltime | all time | -97.0% | -99.9% |
Processa Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2200.00(-91.4%) |
| June 2024 | - | $25.60 K(-49.5%) |
| Mar 2024 | - | $50.70 K(-24.2%) |
| Dec 2023 | $66.90 K(-55.6%) | $66.90 K(-24.7%) |
| Sept 2023 | - | $88.80 K(-18.8%) |
| June 2023 | - | $109.30 K(-15.5%) |
| Mar 2023 | - | $129.40 K(-14.1%) |
| Dec 2022 | $150.60 K(+1935.1%) | $150.60 K(-12.3%) |
| Sept 2022 | - | $171.70 K(+3553.2%) |
| June 2022 | - | $4700.00(-23.0%) |
| Mar 2022 | - | $6100.00(-17.6%) |
| Dec 2021 | $7400.00(-94.0%) | $7400.00(-15.9%) |
| Sept 2021 | - | $8800.00(-71.5%) |
| June 2021 | - | $30.90 K(-52.5%) |
| Mar 2021 | - | $65.00 K(-47.3%) |
| Dec 2020 | $123.30 K(-16.4%) | $123.30 K(-22.4%) |
| Sept 2020 | - | $158.90 K(-22.4%) |
| June 2020 | - | $204.90 K(+59.8%) |
| Mar 2020 | - | $128.20 K(-13.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $147.40 K(>+9900.0%) | $147.40 K(-11.6%) |
| Sept 2019 | - | $166.70 K(-10.7%) |
| June 2019 | - | $186.70 K(-17.2%) |
| Mar 2019 | - | $225.40 K(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2015 | - | $27.50 K(-73.8%) |
| June 2015 | - | $104.90 K(-12.1%) |
| Mar 2015 | - | $119.40 K(-75.8%) |
| Dec 2014 | $494.10 K(+239.6%) | $494.10 K(-75.0%) |
| Sept 2014 | - | $1.97 M(+23.4%) |
| June 2014 | - | $1.60 M(+46.3%) |
| Mar 2014 | - | $1.09 M(+651.5%) |
| Dec 2013 | $145.50 K(-76.0%) | $145.50 K(-6.9%) |
| Sept 2013 | - | $156.20 K(+69.2%) |
| June 2013 | - | $92.30 K(-73.6%) |
| Mar 2013 | - | $349.20 K(-42.4%) |
| Dec 2012 | $606.20 K(-72.4%) | $606.20 K(-45.6%) |
| Sept 2012 | - | $1.11 M |
| Dec 2011 | $2.20 M | - |
FAQ
- What is Processa Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals annual long term debt year-on-year change?
- What is Processa Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals quarterly long term debt year-on-year change?
What is Processa Pharmaceuticals annual long term debt?
The current annual long term debt of PCSA is $66.90 K
What is the all time high annual long term debt for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high annual long term debt is $2.20 M
What is Processa Pharmaceuticals annual long term debt year-on-year change?
Over the past year, PCSA annual long term debt has changed by -$83.70 K (-55.58%)
What is Processa Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of PCSA is $2200.00
What is the all time high quarterly long term debt for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high quarterly long term debt is $1.97 M
What is Processa Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, PCSA quarterly long term debt has changed by -$86.60 K (-97.52%)